Furthermore, the ability of GSP synbiotics to modulate adipose tissue lipogenesis and inflammatory response together with the propionic acid (a SCFA) production in the mice gut can be beneficial to mitigate the risk of NAFLD [188]. The gene discussed is GNAS; the disease is metabolic dysfunction-associated steatotic liver disease.